Status:
UNKNOWN
Treatment of CRF With Syndrome Differentiation of TCM
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Chronic Respiratory Failure
Eligibility:
All Genders
40-80 years
Phase:
EARLY_PHASE1
Brief Summary
Taking the patients with chronic respiratory failure caused by COPD as the research object and the acute exacerbation of COPD as the main outcome index, the investigators hope to establish the syndrom...
Detailed Description
Chronic respiratory failure of chronic obstructive pulmonary disease belongs to the category of "lung distention", "asthma syndrome", "dyspnea" and "phlegm drink" in traditional Chinese medicine. Acco...
Eligibility Criteria
Inclusion
- Inclusion criteria
- patients who meet the diagnostic criteria of COPD in stable stage;
- patients whose blood gas analysis meets PaO2 \< 60mmhg and / or PaCO2 \> 50mmhg in calm breathing at sea level;
- patients whose syndrome differentiation meets the syndrome of heart lung qi deficiency and lung kidney qi deficiency;
- patients whose age is ≥ 40 years and ≤ 80 years;
- patients who are willing to receive treatment and sign the informed consent.
- exclusion criteria:
- chronic respiratory failure caused by bronchial asthma, bronchiectasis, cystic pulmonary fibrosis, lung cancer and other respiratory diseases;
- acute aggravation of the original chronic respiratory failure;
- patients with tumor, serious cardiovascular and cerebrovascular diseases (acute myocardial infarction, cardiac function level 3 and above, stroke, cerebral hemorrhage, etc.) and serious liver and kidney diseases (serious liver disease refers to liver cirrhosis, portal hypertension and varicose bleeding, and serious kidney disease includes dialysis and kidney transplantation) and other people who cannot participate in clinical research;
- pregnant and lactating women;
- patients with mental diseases and mental disorders;
- those who are participating in clinical trials of other drugs, known to be allergic to treatment drugs.
Exclusion
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04694755
Start Date
January 1 2021
End Date
October 1 2022
Last Update
January 6 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.